|
MAT2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.87443418961675E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.19189999945458E-07 |
| Normal-vs-Stage2 |
1.276620E-01 |
| Normal-vs-Stage3 |
3.71900288342886E-11 |
| Normal-vs-Stage4 |
6.42999986588677E-10 |
| Stage1-vs-Stage2 |
6.421400E-01 |
| Stage1-vs-Stage3 |
7.099300E-03 |
| Stage1-vs-Stage4 |
1.520190E-02 |
| Stage2-vs-Stage3 |
7.001900E-02 |
| Stage2-vs-Stage4 |
7.005700E-02 |
| Stage3-vs-Stage4 |
9.642200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.80850009914957E-10 |
| Normal-vs-AfricanAmerican |
2.0009993662029E-11 |
| Normal-vs-Asian |
2.072000E-01 |
| Caucasian-vs-AfricanAmerican |
1.955640E-03 |
| Caucasian-vs-Asian |
8.858400E-01 |
| AfricanAmerican-vs-Asian |
1.525380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.47609949105754E-10 |
| Normal-vs-Female |
1.44459999518176E-08 |
| Male-vs-Female |
5.744000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.34500000004145E-06 |
| Normal-vs-Age(41-60Yrs) |
8.70799999996841E-07 |
| Normal-vs-Age(61-80Yrs) |
1.91769933266528E-11 |
| Normal-vs-Age(81-100Yrs) |
2.215200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.586200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.766750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.861600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.977000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.878000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.473200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.230800E-01 |
| Normal-vs-Grade 2 |
4.010200E-04 |
| Normal-vs-Grade 3 |
1.57890034380159E-10 |
| Normal-vs-Grade 4 |
9.99200722162641E-16 |
| Grade 1-vs-Grade 2 |
8.996600E-01 |
| Grade 1-vs-Grade 3 |
3.366600E-01 |
| Grade 1-vs-Grade 4 |
6.722300E-03 |
| Grade 2-vs-Grade 3 |
5.509900E-02 |
| Grade 2-vs-Grade 4 |
8.31659999978029E-07 |
| Grade 3-vs-Grade 4 |
8.840100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.463570E-01 |
| Normal-vs-ccB subtype |
9.99200722162641E-16 |
| ccA subtype-vs-ccB subtype |
2.6938000052823E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.67589999994422E-07 |
| Normal-vs-N1 |
4.960100E-04 |
| N0-vs-N1 |
1.284190E-01 |
|
|
